With the production of 22 biopharmaceuticals, Iran has been able to save $1 billion, an official with the Vice Presidential Office for Science and Technology says.
Mostafa Qanei, one of the office’s top secretaries, told Fars News Agency, “28 new locally-made biopharmaceuticals are to be introduced in the market in the coming months”.
Qanei noted that the product’s import is extremely costly.
Add new comment